The stress-protectant molecule trehalose mediates fluconazole tolerance in Candida glabrata
Antimicrobial Agents and Chemotherapy · 2025
DOI: 10.1128/aac.01349-24 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2025. Verfasst von Qingjuan Zhu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Laboratory of Molecular Cell Biology, Institute of Botany and Microbiology, KU Leuven, Leuven, Belgium. Hauptthemen laut MEDLINE: Trehalose, Candida glabrata, Fluconazole, Antifungal Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fonds Wetenschappelijk Onderzoek (FWO), Max Planck Society, Overseas study program of Guangzhou Elite Project.
Abstract (Originalsprache)
The incidence of non- albicans Candida infections has witnessed a substantial rise in recent decades. Candida glabrata (Nakaseomyces glabratus ), an opportunistic human fungal pathogen, is accountable for both superficial mucosal and life-threatening bloodstream infections, particularly in immunocompromised individuals. Distinguished by its remarkable resilience to environmental stressors, C. glabrata exhibits intrinsic tolerance to azoles and a high propensity to swiftly develop azole resistance during treatment. The molecular mechanism for the high tolerance is not fully understood. In this work, we investigated the possible role of trehalose in this tolerance. We generated mutants in the C. glabrata TPS1 , TPS2 , and NTH1 genes, encoding trehalose 6-phosphate synthase (Tps1), trehalose 6-phosphate phosphatase (Tps2), and neutral trehalase (Nth1), respectively. As expected, the tps1∆ strain cannot grow on glucose. The tps2 ∆ strain demonstrated diminished trehalose accumulation and very high levels of trehalose 6-phosphate (T6P), the biosynthetic intermediate, in comparison to the wild-type (WT) strain. Whereas these higher T6P levels did not affect growth, the lower trehalose levels clearly resulted in lower environmental stress tolerance and a lower susceptibility to fluconazole. More interestingly, the tps2∆ strain completely lost tolerance to fluconazole, characterized by the absence of slow growth at supra-MIC concentrations of this drug. All these phenotypes are reversed in the nth1 ∆ strain, which accumulates high levels of trehalose. Our findings underscore the role of trehalose in enabling tolerance toward fluconazole in C. glabrata . We further show that the change in tolerance is a result of the effect that trehalose has on the sterol pattern in the cell.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biology, Laboratory of Molecular Cell Biology, Institute of Botany and Microbiology, KU Leuven, Leuven, Belgium.
- Max Planck Institute of Molecular Plant Physiology, Potsdam-Golm, Germany.
- Leuven One Health Institute, KU Leuven, Leuven, Belgium.
ORCID-Profile: Qingjuan Zhu, Stefanie Wijnants, Wouter Van Genechten, Patrick Van Dijck
Förderung
- Fonds Wetenschappelijk Onderzoek (FWO)
- Max Planck Society
- Overseas study program of Guangzhou Elite Project
Zitieren
APA
Zhu, Q., Wijnants, S., Feil, R., Van Genechten, W., Vergauwen, R., Van Goethem, O., Lunn, J. E., Van Ende, M., & Van Dijck, P. (2025). The stress-protectant molecule trehalose mediates fluconazole tolerance in Candida glabrata. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01349-24
Vancouver
Zhu Q, Wijnants S, Feil R, Van Genechten W, Vergauwen R, Van Goethem O, et al. The stress-protectant molecule trehalose mediates fluconazole tolerance in Candida glabrata. Antimicrobial Agents and Chemotherapy. 2025. doi:10.1128/aac.01349-24
BibTeX
@article{Zhu2025,
author = {Zhu, Qingjuan and Wijnants, Stefanie and Feil, Regina and Van Genechten, Wouter and Vergauwen, Rudy and Van Goethem, Odessa and Lunn, John E and Van Ende, Mieke and Van Dijck, Patrick},
title = {The stress-protectant molecule trehalose mediates fluconazole tolerance in Candida glabrata},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2025},
doi = {10.1128/aac.01349-24}
}
EUVIMED